These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 21771992)
1. Genetics and variable drug response. Wilke RA; Dolan ME JAMA; 2011 Jul; 306(3):306-7. PubMed ID: 21771992 [No Abstract] [Full Text] [Related]
2. Pharmacogenetics: The right drug for you. Drew L Nature; 2016 Sep; 537(7619):S60-2. PubMed ID: 27602742 [No Abstract] [Full Text] [Related]
3. The promises of personalized medicine. Cascorbi I Eur J Clin Pharmacol; 2010 Aug; 66(8):749-54. PubMed ID: 20563567 [No Abstract] [Full Text] [Related]
4. Pharmacogenomics and Global Precision Medicine in the Context of Adverse Drug Reactions: Top 10 Opportunities and Challenges for the Next Decade. Alessandrini M; Chaudhry M; Dodgen TM; Pepper MS OMICS; 2016 Oct; 20(10):593-603. PubMed ID: 27643672 [TBL] [Abstract][Full Text] [Related]
5. Facilitating clinical implementation of pharmacogenomics. Mrazek DA; Lerman C JAMA; 2011 Jul; 306(3):304-5. PubMed ID: 21771991 [No Abstract] [Full Text] [Related]
8. Implementation of Pharmacogenetics at Cincinnati Children's Hospital Medical Center: Lessons Learned Over 14 Years of Personalizing Medicine. Ramsey LB; Prows CA; Zhang K; Saldaña SN; Sorter MT; Pestian JP; Wenstrup RJ; Vinks AA; Glauser TA Clin Pharmacol Ther; 2019 Jan; 105(1):49-52. PubMed ID: 30058217 [No Abstract] [Full Text] [Related]
9. What do we need to transfer pharmacogenetics findings into the clinic? Slob EMA; Vijverberg SJH; Pijnenburg MW; Koppelman GH; Maitland-van der Zee AH Pharmacogenomics; 2018 May; 19(7):589-592. PubMed ID: 29701121 [No Abstract] [Full Text] [Related]
10. Pharmacogenomics: paving the path to personalized medicine. Patrinos GP; Innocenti F Pharmacogenomics; 2010 Feb; 11(2):141-6. PubMed ID: 20136354 [TBL] [Abstract][Full Text] [Related]
11. High-throughput framework for genetic analyses of adverse drug reactions using electronic health records. Zheng NS; Stone CA; Jiang L; Shaffer CM; Kerchberger VE; Chung CP; Feng Q; Cox NJ; Stein CM; Roden DM; Denny JC; Phillips EJ; Wei WQ PLoS Genet; 2021 Jun; 17(6):e1009593. PubMed ID: 34061827 [TBL] [Abstract][Full Text] [Related]
12. Prediction of drug response and adverse drug reactions: From twin studies to Next Generation Sequencing. Lauschke VM; Ingelman-Sundberg M Eur J Pharm Sci; 2019 Mar; 130():65-77. PubMed ID: 30684656 [TBL] [Abstract][Full Text] [Related]
13. PARC report: health outcomes and value of personalized medicine interventions: impact on patient care. Mitropoulou C; Litinski V; Kabakchiev B; Rogers S; P Patrinos G Pharmacogenomics; 2020 Jul; 21(11):797-807. PubMed ID: 32635813 [TBL] [Abstract][Full Text] [Related]
14. Databases in the area of pharmacogenetics. Sim SC; Altman RB; Ingelman-Sundberg M Hum Mutat; 2011 May; 32(5):526-31. PubMed ID: 21309040 [TBL] [Abstract][Full Text] [Related]
15. Molecular diagnostics as a predictive tool: genetics of drug efficacy and toxicity. Johnson JA; Evans WE Trends Mol Med; 2002 Jun; 8(6):300-5. PubMed ID: 12067617 [TBL] [Abstract][Full Text] [Related]
16. Genome-wide association studies of drug response and toxicity: an opportunity for genome medicine. Giacomini KM; Yee SW; Mushiroda T; Weinshilboum RM; Ratain MJ; Kubo M Nat Rev Drug Discov; 2017 Jan; 16(1):1. PubMed ID: 27885282 [No Abstract] [Full Text] [Related]
17. Health: Make precision medicine work for cancer care. Rubin MA Nature; 2015 Apr; 520(7547):290-1. PubMed ID: 25877189 [No Abstract] [Full Text] [Related]
18. Pharmacogenomics at the center of precision medicine: challenges and perspective in an era of Big Data. Primorac D; Bach-Rojecky L; Vađunec D; Juginović A; Žunić K; Matišić V; Skelin A; Arsov B; Boban L; Erceg D; Ivkošić IE; Molnar V; Ćatić J; Mikula I; Boban L; Primorac L; Esquivel B; Donaldson M Pharmacogenomics; 2020 Jan; 21(2):141-156. PubMed ID: 31950879 [TBL] [Abstract][Full Text] [Related]